✦ LIBER ✦

Rituximab (Anti-cd20 Monoclonal Antibody) in Children with Chronic Refractory Symptomatic Immune Thrombocytopenic Purpura: Efficacy and Safety of Treatment

✍ Scribed by Emilia Parodi; Bruno Nobili; Silverio Perrotta; Sofia Maria Rosaria Matarese; Giovanna Russo; Maria Licciardello; Marco Zecca; Franco Locatelli; Simone Cesaro; Gianni Bisogno; Paola Giordano; Domenico De Mattia; Ugo Ramenghi

Book ID: 111835846
Publisher: Carden Jennings Publishing
Year: 2006
Tongue: English
Weight: 111 KB
Volume: 84
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.e0518

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of B-cell deplet

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

✍ Nichola Cooper; Roberto Stasi; Susanna Cunningham-Rundles; Michael A. Feuerstein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Treatment of relapsed idiopathic thrombo

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study

✍ A.A.N. Giagounidis; J. Anhuf; P. Schneider; U. Germing; D. Söhngen; K. Quabeck; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Clinical remission following monoclonal

Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura

✍ Maria Moschovi; Georgios Trimis; Helini Pergantou; Heleni Platokouki; Eleni Vrac 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Serum sickness with an elevated level of

Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura

✍ Shoko Goto; Hiroaki Goto; Reo Tanoshima; Hiromi Kato; Hiroyuki Takahashi; Osamu 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 201 KB

Treatment of relapsed B-cell non-Hodgkin

Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy

✍ van der Kolk, L E; Grillo-López, A J; Baars, J W; van Oers, M H J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB